BA058

abaloparatide · Radius Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BA058, covering 2010-07-29 to 2010-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis [Phase 2]

See pricing